Prostate cancer gene therapy: Outcome of basic research and clinical trials

Yasutomo Nasu, B. Djavan, M. Marberger, H. Kumon

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

With the advances in genetic engineering, tumor biology, and immunology, gene therapy has been recognized as a promising new treatment option for cancer, including prostate cancer. Several clinical trials of prostate cancer gene therapy currently underway are using therapeutic genes, including suicide genes, immunomodulatory genes, tumor suppressor genes, and antioncogenes. Although gene therapy for prostate cancer as a clinical alternative is still at an early stage that requires several technological breakthroughs, information obtained from clinical trials indicates the full potential of prostate cancer gene therapy. Concordant progress in basic research and gene therapy technology will ready prostate cancer gene therapy for widescale use in the future. In this report, the general concept and current progress in prostate cancer gene therapy are summarized.

Original languageEnglish
Pages (from-to)185-190
Number of pages6
JournalTechniques in Urology
Volume5
Issue number4
Publication statusPublished - 1999

Fingerprint

Neoplasm Genes
Genetic Therapy
Prostatic Neoplasms
Outcome Assessment (Health Care)
Clinical Trials
Tumor Suppressor Genes
Genes
Genetic Engineering
Allergy and Immunology
Suicide
Technology
Therapeutics
Research
Neoplasms

Keywords

  • Gene therapy
  • Genes
  • Outcome
  • Prostate cancer

ASJC Scopus subject areas

  • Urology

Cite this

Prostate cancer gene therapy : Outcome of basic research and clinical trials. / Nasu, Yasutomo; Djavan, B.; Marberger, M.; Kumon, H.

In: Techniques in Urology, Vol. 5, No. 4, 1999, p. 185-190.

Research output: Contribution to journalArticle

Nasu, Y, Djavan, B, Marberger, M & Kumon, H 1999, 'Prostate cancer gene therapy: Outcome of basic research and clinical trials', Techniques in Urology, vol. 5, no. 4, pp. 185-190.
Nasu, Yasutomo ; Djavan, B. ; Marberger, M. ; Kumon, H. / Prostate cancer gene therapy : Outcome of basic research and clinical trials. In: Techniques in Urology. 1999 ; Vol. 5, No. 4. pp. 185-190.
@article{9a0b6ed08a514e6d8dcace26b9268ec1,
title = "Prostate cancer gene therapy: Outcome of basic research and clinical trials",
abstract = "With the advances in genetic engineering, tumor biology, and immunology, gene therapy has been recognized as a promising new treatment option for cancer, including prostate cancer. Several clinical trials of prostate cancer gene therapy currently underway are using therapeutic genes, including suicide genes, immunomodulatory genes, tumor suppressor genes, and antioncogenes. Although gene therapy for prostate cancer as a clinical alternative is still at an early stage that requires several technological breakthroughs, information obtained from clinical trials indicates the full potential of prostate cancer gene therapy. Concordant progress in basic research and gene therapy technology will ready prostate cancer gene therapy for widescale use in the future. In this report, the general concept and current progress in prostate cancer gene therapy are summarized.",
keywords = "Gene therapy, Genes, Outcome, Prostate cancer",
author = "Yasutomo Nasu and B. Djavan and M. Marberger and H. Kumon",
year = "1999",
language = "English",
volume = "5",
pages = "185--190",
journal = "Techniques in Urology",
issn = "1079-3259",
publisher = "Raven Press",
number = "4",

}

TY - JOUR

T1 - Prostate cancer gene therapy

T2 - Outcome of basic research and clinical trials

AU - Nasu, Yasutomo

AU - Djavan, B.

AU - Marberger, M.

AU - Kumon, H.

PY - 1999

Y1 - 1999

N2 - With the advances in genetic engineering, tumor biology, and immunology, gene therapy has been recognized as a promising new treatment option for cancer, including prostate cancer. Several clinical trials of prostate cancer gene therapy currently underway are using therapeutic genes, including suicide genes, immunomodulatory genes, tumor suppressor genes, and antioncogenes. Although gene therapy for prostate cancer as a clinical alternative is still at an early stage that requires several technological breakthroughs, information obtained from clinical trials indicates the full potential of prostate cancer gene therapy. Concordant progress in basic research and gene therapy technology will ready prostate cancer gene therapy for widescale use in the future. In this report, the general concept and current progress in prostate cancer gene therapy are summarized.

AB - With the advances in genetic engineering, tumor biology, and immunology, gene therapy has been recognized as a promising new treatment option for cancer, including prostate cancer. Several clinical trials of prostate cancer gene therapy currently underway are using therapeutic genes, including suicide genes, immunomodulatory genes, tumor suppressor genes, and antioncogenes. Although gene therapy for prostate cancer as a clinical alternative is still at an early stage that requires several technological breakthroughs, information obtained from clinical trials indicates the full potential of prostate cancer gene therapy. Concordant progress in basic research and gene therapy technology will ready prostate cancer gene therapy for widescale use in the future. In this report, the general concept and current progress in prostate cancer gene therapy are summarized.

KW - Gene therapy

KW - Genes

KW - Outcome

KW - Prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=0032726494&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032726494&partnerID=8YFLogxK

M3 - Article

C2 - 10591255

AN - SCOPUS:0032726494

VL - 5

SP - 185

EP - 190

JO - Techniques in Urology

JF - Techniques in Urology

SN - 1079-3259

IS - 4

ER -